EX-FILING FEES 6 tm2421544d2_ex-filingfees.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-3

(Form Type)

 

AEON Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
 

Security

Class Title

 

Fee

Calculation

or Carry
Forward

Rule

 

Amount

Registered(3)

 

Proposed

Maximum

Offering
Price Per

Unit

 

Maximum

Aggregate
Offering
Price(3)

  Fee
Rate
 

Amount
of

Registration

Fee

 

Carry

Forward

Form

Type

 

Carry

Forward

File

Number

 

Carry

Forward

Initial

Effective

Date

 

Filing
Fee

Previously

Paid In

Connection

with

Unsold

Securities

to be

Carried

Forward

Newly Registered Securities

Fees to

Be Paid

  Equity   Class A Common
Stock, par
value $0.0001
per share(1)
                             
  Equity  

Preferred
Stock, par
value

$0.0001
per share(1)

                             
  Debt  

Debt

Securities

                             
  Other   Warrants                              
  Other  

Purchase

Contracts

                             
  Other   Units                              
  Unallocated
(Universal)
Shelf
  (1)   457(o)   (1)   (2)   $200,000,000   0.0001476   $29,520                

Fees

Previously

Paid

  N/A   N/A   N/A   N/A   N/A   N/A       N/A                
Total Offering Amounts       $200,000,000(3)       $29,520                
Total Fees Previously Paid                              
Total Fee Offsets                              
Net Fee Due               $29,520                

 

(1) An indeterminate number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an indeterminate number of securities is being registered as may be issued from time to time upon conversion of or exchange for preferred stock that provide for conversion or exchange, upon exercise of warrants, or pursuant to any anti-dilution provisions of any such securities. Includes rights to acquire shares of Class A common stock, par value $0.0001 per share (“common stock”) or preferred stock, par value $0.0001 per share (“preferred stock”) of AEON Biopharma, Inc. (the “Registrant”) under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(2) The proposed maximum offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and related disclosure on Form S-3. 

(3) Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of preferred stock or upon exercise of warrants to purchase common stock or preferred stock registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $200,000,000.